Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer: the STEP Trial

NCT04679675 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT04679675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04679675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer: the STEP Trial
Lead sponsor
Kaiser Permanente
Phase
Not applicable
Overall status
Completed
Start date
November 20, 2020
Completion date
July 29, 2023
Enrollment
32,771 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, cervical dysplasia, genital neoplasms, female, hpv infection, hpv-related cervical carcinoma, hpv-related malignancy, human papilloma virus, neoplasms, neoplasms by site, urogenital neoplasms, uterine cervical diseases, uterine cervical neoplasm, uterine diseases, uterine neoplasms